Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 42%
Buy 42%
Hold 16%
Sell 0%
Strong Sell 0%

Bulls say

Intuitive Surgical is a global technology leader in robotic-assisted, minimally invasive surgery, and with over 10,000 da Vinci systems placed worldwide, the company has established a strong market presence and continues to expand its footprint in emerging markets. With a growing number of installations in the US and a positive outlook for procedure growth, the company's revenue and earnings are expected to see steady growth in the coming years. Risks to consider include competition and potential challenges in the procedural and capital purchasing environment.

Bears say

Intuitive Surgical is facing various challenges in the near term, including increased competition in certain regions, pricing pressure, and policy-driven headwinds in China and Japan. While the company's ecosystem and key metrics such as procedure growth and I&A per procedure remain strong, these challenges could potentially impact long-term adoption and growth. In the first quarter of 2026, total Dv installation was 11,395 and average system utilization increased by 4% in the US, but OUS volumes in China, Japan, and Europe were impacted by these challenges.

Intuitive Surgical (ISRG) has been analyzed by 19 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 42% recommend Buy, 16% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 19 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Jun 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $596.05, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $596.05, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.